Agios Pharmaceuticals Q3 EPS $(1.09) Beats $(1.20) Estimate, Sales $55.385M Beat $53.208M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.20) by 9.17 percent. This is a 38.76 percent increase over losses of $(1.78) per share
Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.09) per share which beat the analyst consensus estimate of $(1.20) by 9.17 percent. This is a 38.76 percent increase over losses of $(1.78) per share from the same period last year. The company reported quarterly sales of $55.385 million which beat the analyst consensus estimate of $53.208 million by 4.09 percent. This is a 330.01 percent increase over sales of $12.880 million the same period last year.